Pharmacotherapy of post-traumatic stress disorder

Drugs of Today

Volumn 42, Issue 12, 2006, Pages 803-809

  Opler, Lewis A ^a,c,d   Grennan, Michelle S ^b   Opler, Mark G ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LONG ISLAND UNIVERSITY   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BUSPIRONE; FLUOXETINE; FLUVOXAMINE; LAMOTRIGINE; OLANZAPINE; PAROXETINE; PLACEBO; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; VALPROIC ACID;

AVOIDANCE BEHAVIOR; BIPOLAR DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; MENTAL DISEASE; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

COMORBIDITY; HUMANS; SEROTONIN UPTAKE INHIBITORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 33846987148     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2006.42.12.1025704     Document Type: Review

References (39)

1. Courtois, C.A. Complex trauma, complex reactions: Assessment and treatment. Psychotherapy Theory Res Pract Train 2004, 41: 412-25.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edition. American Psychiatric Association, Washington, D.C., 1980.
3. Kessler, R.C., Sonnega, A., Bromet, E. et al. Post-traumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry 1995, 52: 1048-60.
4. Terr, L.C. Children of Chowchilla: A study of psychic trauma. Psychoanal Study Child 1979, 34: 552-623.
5. Herman, J.L. Complex PTSD: A syndrome in survivors of prolonged and repeated trauma. J Trauma Stress 1992, 3: 377-91.
6. Herman, J.L. Trauma and Recovery. Basic Books, New York, 1997.
7. van der Kolk, B.A., Pelcovitz, D., Roth, S., Mandel, F.S. Dissociation, somatization, and affect dysregulation: The complexity of adaptation to trauma. Am J Psychiatry 1996, 153: 83-93.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision. American Psychiatric Association, Washington, D.C., 2000.
9. World Health Organization. The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. World Health Organization, Geneva, 1994.
10. Kuhler, T., Stachetzki, R. Differential diagnostics of borderline disorder and complex traumatic stress disorder. Psychotherapeut 2005, 50: 25-32.
11. Fish, V. Some gender differences in diagnosing traumatized women. In: Caplan, P.J., Cosgrove, L. (Eds.). Bias in Psychiatric Diagnosis. A Project of the Association for Women in Psychology. Jason Aronson, Inc., Lanham, MD, USA, 2004, 213-20.
12. Chard, K.M., Widiger, T.A. Abuse, Coping, and Treatment. J Psychotherapy Integration 2005, 15: 74-88.
13. Jeffries, J.J. The trauma of being psychotic: A neglected element in the management of chronic schizophrenia? Can Psychiatr Assoc J 1977, 22: 199-206.
14. Butler, R.W., Mueser, K.T., Sprock, J., Braff, D.L. Positive symptoms of psychosis in post-traumatic stress disorder. Biol Psychiatry 1996, 39: 839-844.
15. Centofanti, A.T., Smith, D.I., Altieri, T. Post-traumatic stress disorder as a reaction to the experience of psychosis and its sequelae. Clin Psychol 2005, 9: 15-23.
16. Morrison, A.P., Frame, L., Larkin, W. Relationships between trauma and psychosis: A review and integration. Br J Clin Psychology 2003, 42: 331-54.
17. Muenzenmaier, K., Castille, D.M., Shelley, A.-M. et al. Comorbid post-traumatic stress disorder and schizophrenia. Psychiatr Ann 2005, 35: 2-7.
18. Brady, K., Pearlstein, T., Asnis, G.M, et al. Efficacy and safety of sertraline treatment of post-traumatic stress disorder: A randomized controlled trial. JAMA 2000, 283: 1837-44.
19. Davidson, J.R., Rothbaum, B.O., van der Kolk, B. A. et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of post-traumatic stress disorder. Arch Gen Psychiatry 2001, 58: 485-92.
20. Marshall, R.D., Schneirer, F.R., Fallon, B.A. et al. An open trial of paroxetine in patients with noncombat-related, chronic post-traumatic stress disorder. J Clin Psychopharmacol 1998, 18: 10-18.
21. Marshall, R.D., Beebe, K.L., Oldham, J.M. et al. Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study. Am J Psychiatry 2001, 158: 1982-1988.
22. Nagy, L., Marshall, R.D. PTSD psychopharmacology basics for non-physicians and beginning psychiatrists. NC-PTSD Clinical Quarterly 2002, 11: 33-9.
23. van der Kolk, B.A, Ford, J., Cloitre, M. Complex PTSD across the lifespan: Implications for DSM-V. Syllabus and Scientific Proceedings in Summary Form: The 159th Annual Meeting of the American Psychiatric Association, 2006.
24. Ramirez, P.M., Opler, L.A. Hypnosis as a therapeutic tool in the treatment of adult survivors of childhood incest. Int J Professional Hypnosis 1993, 7: 33-8.
25. Shapiro, F. Eye Movement Desensitization and Reprocessing: Basic Principles, Protocols, and Procedures. Guilford Publications, New York, 1995.
26. Duffy, J.D., Malloy, P.F. Efficacy of buspirone in the treatment of post-traumatic stress disorder: An open trial. Ann Clin Psychiatry 1994, 6: 33-7.
27. Schoenfeld, F.B., Marmar, C.R., Neylan, T.C. Current concepts in pharmacotherapy for post-traumatic stress disorder. Psychiatr Serv 2004, 55: 519-31.
28. Fesler, F.A. Valproate in combat-related post-traumatic stress disorder. J Clin Psychiatry 1991, 52: 361-4.
29. Akuchekian, S., Amanat, S. The comparison of topiramate and placebo in the treatment of post-traumatic stress disorder: A randomized, double-blind study. J Res Med Sci 2004, 5: 42-6.
30. Blake, D.D., Weathers, F.W., Nagy, L.M. et al. Clinician-Administered Scale for DSM-IV. National Center for Post-traumatic Stress Disorder, Boston, MA, and West Haven, CT, USA, 1995.
31. Stein, M.B., Kline, N., Matloff, J. Adjunctive olanzapine for SSRI-resistant combat-related PTSD. Am J Psychiatry 2002, 159: 1777-9.
32. Bartzokis, G., Freeman, T., Roca, V., et al. Risperidone for patients with chronic combat-related stress disorder. 154th Annual Meeting of the American Psychiatric Association, New Orleans 2001, Abst. NR 562: 152.
33. Kay, S.R., Opler, L.A., Fiszbein, A. Positive and Negative Syndrome Scale (PANSS) Manual, Multi-Health Systems Inc.: Toronto, Ontario, Canada, 2006.
34. Reich, D.B., Winternitz, S., Hennen, J., et al. A preliminary study of risperidone in the treatment of post-traumatic stress disorder related to childhood abuse in women. J Clin Psychiatry 2004, 65: 1601-6.
35. Mueser, K.T., Trumbeta, S.L., Rosenberg, S.D. et al. Trauma and post-traumatic stress disorder in severe mental illness. J Consult Clin Psychol 1998, 66: 493-9.
36. Hertzberg, M.A., Buttefield, M.I., Feldman, M.E. et al. A preliminary study of lamotrigine for the treatment of post-traumatic stress disorder. Biol Psychiatry 1999, 45: 1226-9.
37. Sokolski, K.N., Denson, T.F., Lee, R.T., et al. Quetiapine for treatment of refractory symptoms of combat-related post-traumatic stress disorder. Military Med 2003, 168: 486-9.
38. Opler, LA, Muenzenmaier K, Shelley AM, Grennan MS. Symptoms of Trauma Scale (SOTS) Manual. Multi-Health Systems, Inc., Toronto, Ontario, Canada, in press.
39. Foa, E.B., Davidson, J.R., Frances, A. The expert consensus guidelines series: Treatment of post-traumatic stress disorder. J Clin Psychiatry 1999, 60 (Suppl. 16): 1-76.